ClinicalTrials.Veeva

Menu

Clinical Evaluation of FreeO2 (Version 4) in All Patients Receiving Oxygen (FreeO24G)

L

Laval University

Status

Completed

Conditions

Asthma
Respiratory Failure
Respiratory Disease
Pneumonia
COPD Exacerbation

Treatments

Device: FreeO2

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Evaluation of automatic titration of oxygen with a new version of FreeO2 (V4)

Full description

In the previous studies, the investigators used many times automatic titration of oxygen on spontanous breathing patient (FreeO2 device) with a prototype develop in our lab in collaboration with Laval university. In this study, we want to evaluate the new version of the FreeO2 device (V4)

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > or = 18 years old
  • Patient receiving oxygen between 1 to 6 lpm for medical pathology
  • Admitted to a medical service for less than 72 hours (emergency room not included)

Exclusion criteria

  • Unreliable SpO2 signal
  • Emergency or intensive care hospitalization
  • Absence of NIV or intubation criteria at baseline
  • Sleep apnea not paired
  • Long-term Oxygen Therapy
  • Active delirium and cognitive impairment preventing informed consent

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Automated oxygen adjustment
Other group
Description:
All patient in this study have automatic oxygen titration and automatic oxygen weanning
Treatment:
Device: FreeO2

Trial contacts and locations

1

Loading...

Central trial contact

François Lellouche; Pierre-alexandre Bouchard

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems